All In Biotech

Free tool

FAERS Monitor: Omnipred

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017469 or its brand name (Omnipred, Prednisolone Acetate). Reports on generic versions are filed under their own applications.

Reports

8,432

Serious

3,975

47% of reports

Hospitalization

1,566

Death reported

454

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • treatment failure1,251
  • drug ineffective768
  • recalled product administered763
  • no adverse event641
  • off label use537
  • eye pain473
  • eye irritation314
  • vision blurred282
  • fatigue255
  • headache239
  • diarrhoea220
  • condition aggravated209
  • pain204
  • ocular hyperaemia198
  • pyrexia186

Reports by year received

View as table
YearReports
200417
200531
200635
200770
2008130
200951
201070
201170
2012160
201393
2014125
2015243
2016483
2017280
2018404
2019471
20201,633
2021432
2022505
2023588
2024628
2025663
20261,250

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,727 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
recalled product administeredSignal763216.8202.0150,669
treatment failureSignal1,25138.236.344,811
eye painSignal47321.119.38,976
eye irritationSignal31413.712.33,667
ocular hyperaemiaSignal19810.49.11,679
no adverse eventSignal6418.98.24,480
vision blurredSignal2825.14.6938
condition aggravated2091.71.562
off label use5371.51.4102
drug ineffective7681.51.4116
pyrexia1861.31.216
headache2391.00.81
diarrhoea2200.90.76
pain2040.80.77
fatigue2550.80.711

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.